|
20.08.25 - 07:03
|
Heidelberg University Hospital expands its particle therapy program with IBA′s Proteus®ONE solution (GlobeNewswire EN)
|
|
Louvain-La-Neuve, Belgium, August 20, 2025 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world's leading provider of proton therapy solutions for the treatment of cancer and Heidelberg University Hospital (Universitätsklinikum Heidelberg AöR, UKHD) announce today that they have signed a contract to install a Proteus®ONE1 compact proton therapy solution to be located on the University campus in Heidelberg, Germany. The first payment has been received....
|
|
19.08.25 - 16:18
|
GOGL - Results of the Special General Meeting (GlobeNewswire EN)
|
|
HAMILTON, Bermuda, 19 August 2025 – Golden Ocean Group Limited (NASDAQ: GOGL & Euronext Oslo Børs: GOGL) ("Golden Ocean") advises that a Special General Meeting ("SGM") of the shareholders of Golden Ocean was held today, 19 August 2025, at 09:00 (local time) at Hamilton Princess and Beach Club, 76 Pitts Bay Road, Hamilton HM 08. ...
|
|
19.08.25 - 07:03
|
argenx to Host R&D Webinar Highlighting ARGX-119 on September 16, 2025 (GlobeNewswire EN)
|
|
August 19, 2025Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced it will host a webinar, titled “R&D Spotlight | Pioneering MuSK Biology with ARGX-119” on Tuesday, September 16, 2025, at 2:00pm ET....
|
|
|
18.08.25 - 13:03
|
Signify share repurchase period update (GlobeNewswire EN)
|
|
Press ReleaseAugust 18, 2025Signify share repurchase period update Eindhoven, the Netherlands – Signify (Euronext: LIGHT), the world leader in lighting, today announced that it has repurchased 45,036 shares in the period August 05 to August 15, 2025. The shares were repurchased at an average price of EUR 22.38 per share and an aggregate amount of EUR 1.0 million. Signify will use these repurchased shares to reduce the company's capital.The repurchases were made as part of the company's share repurchase program, which was announced on February 4, 2025. The total number of shares repurchased under this program to date is 4,365,026 shares for a total consideration of EUR 90.1 million. Details on the share buyback transactions can be found here....
|
|
|
|
14.08.25 - 17:33
|
Aker ASA: Mandatory Notification of Trade (PR Newswire)
|
|
OSLO, Norway, Aug. 14, 2025 /PRNewswire/ -- Aker ASA today bought 9,056 own shares at an average price of NOK 688.2461 per share. The shares were acquired on Euronext Oslo Børs as part of the company's share program for employees. This gives Aker ASA a new holding of 42,567 own shares.......
|
|
14.08.25 - 08:36
|
CMB.TECH Business update Q2 2025 results (GlobeNewswire EN)
|
|
Antwerp, Aug. 14, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT & Euronext: CMBT) (“CMBT”, “CMB.TECH” or “the Company”) will release its second quarter 2025 earnings prior to market opening on Thursday 28 August 2025 and will host a conference call at 8 a.m. EST / 2 p.m. CET to discuss the results for the quarter. Due to the proximity of the expected closing date of the contemplated stock-for-stock merger between CMB.TECH and Golden Ocean Group Limited (“Golden Ocean”), CMB.TECH already provides preliminary figures related to the Q2 2025 results in this business update. ...
|
|
|
|
11.08.25 - 13:03
|
Signify share repurchase period update (GlobeNewswire EN)
|
|
Press ReleaseAugust 11, 2025Signify share repurchase period update Eindhoven, the Netherlands – Signify (Euronext: LIGHT), the world leader in lighting, today announced that it has repurchased 63,368 shares in the period August 04 to August 08, 2025. The shares were repurchased at an average price of EUR 21.12 per share and an aggregate amount of EUR 1.3 million. Signify will use these repurchased shares to reduce the company's capital.The repurchases were made as part of the company's share repurchase program, which was announced on February 4, 2025. The total number of shares repurchased under this program to date is 4,319,990 shares for a total consideration of EUR 89.1 million. Details on the share buyback transactions can be found here....
|
|
11.08.25 - 09:01
|
Akobo Minerals secures Ethiopian Sovereign Fund′s first international investment (Cision)
|
|
OSLO, 11 August 2025 – Akobo Minerals AB (publ) (Euronext and Frankfurt: AKOBO) (OTC: AKOBF), a Scandinavian-based Ethiopian gold producer, proudly announces a historic investment from Ethiopian Investment Holdings (EIH), the Sovereign Investment Fund of Ethiopia. EIH will obtain a 7.4% ownership stake in Akobo Minerals through the subscription of 15,000,000 new shares in a private placement towards EIH, at a subscription price per share of USD 0.20, raising total gross proceeds of USD 3,000,000. This marks the first time Ethiopia's sovereign fund has invested in an international company....
|
|
|
|
06.08.25 - 20:30
|
ONWARD Medical gibt Ernennung von Lucas Buchanan als Vorstandsmitglied bekannt (GlobeNewswire)
|
|
EINDHOVEN, Niederlande, Aug. 06, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD und US OTCQX: ONWRY), das führende Neurotechnologieunternehmen, das Pionierarbeit bei Therapien zur Wiederherstellung der Bewegungsfähigkeit, Funktion und Unabhängigkeit von Menschen mit Rückenmarksverletzungen (Spinal cord injury, SCI) und anderen Bewegungseinschränkungen leistet, gibt heute die Ernennung von Lucas Buchanan als nicht geschäftsführendes Mitglied seines Vorstands bekannt....
|
|
06.08.25 - 07:33
|
ONWARD Medical Announces the Appointment of Lucas Buchanan to its Board of Directors (GlobeNewswire EN)
|
|
EINDHOVEN, The Netherlands, Aug. 06, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injury (SCI) and other movement disabilities, today announces the appointment of Lucas Buchanan as a non-executive member of its Board of Directors....
|
|
|
|
|